Start a live chat
1-800-870-4800
NMN and aging —
the full picture
of where the biology stands.
The science of NMN and aging is not a single claim — it is a mechanistic architecture. A molecule, a pathway, a family of enzymes, and a set of cellular maintenance systems whose connections to the biology of aging are specific, documented, and grounded in decades of research. This article maps where those connections are real, where they are still developing, and where they do not exist — because precision is what the science deserves.
I
What the science of NMN
actually establishes — and what it does not.
There is a difference between what the science of NMN and aging has established at the mechanistic level and what the popular conversation around it often implies it has established. The mechanistic biology — the specific connections between NAD+ availability, sirtuin activity, PARP-mediated DNA repair, mitochondrial function, and the hallmarks of aging — is real, documented, and grounded in decades of molecular biology research. The human clinical evidence for specific outcomes — what NMN supplementation actually produces in measurable health terms across populations — is younger, less complete, and still actively accumulating. These are different bodies of evidence, and treating them as equivalent is where science communication in the longevity space most commonly loses precision.
The mechanistic story is specific. NAD+ is a molecule whose availability governs the activity of the sirtuin enzymes that maintain cellular integrity, the PARP enzymes that execute DNA repair, and the mitochondrial systems that produce cellular energy. As the body ages, NAD+ availability declines through a documented mechanism: the rate-limiting enzyme of the Salvage Pathway, NAMPT, loses activity; the NAD+-consuming enzyme CD38 rises with age-related inflammation; and the combined deficit progressively constrains the cellular maintenance systems that NAD+ supports. NMN — as what NAMPT produces, and as the direct precursor to NAD+ — occupies a specific position in this story that is grounded in pathway biology rather than in general wellness claims.
NAD+ sits at the center of this picture not as a cure for aging but as a substrate — a molecule whose availability governs the activity of the sirtuin enzymes that maintain cellular integrity, the PARP enzymes that execute DNA repair, and the mitochondrial systems that produce cellular energy. As the body ages, NAD+ availability declines through a documented mechanism: the rate-limiting enzyme of the Salvage Pathway, NAMPT, loses activity; the NAD+-consuming enzyme CD38 rises with age-related inflammation; and the combined deficit progressively constrains the cellular maintenance systems that NAD+ supports. Understanding this story precisely — not as a product promise but as a biological mechanism — is the foundation of how to think clearly about NMN and aging.
The mechanistic story
is not speculation.
The gap between mechanism
and confirmed human outcome
is real — and naming it
is part of what makes
the science worth trusting.
The Molecular Foundation
Six mechanisms that connect
NAD+ to the biology of aging.
Each of these mechanisms is independently documented in the aging biology literature. All research referenced here was conducted independently and did not involve any specific Codeage product.
NAD+ levels in multiple human and animal tissues — skeletal muscle, liver, brain, adipose tissue, and blood — have been documented to fall substantially with age. This decline is the downstream consequence of two converging mechanisms: reduced NAMPT activity, which slows the Salvage Pathway's rate-limiting conversion of nicotinamide to NMN; and rising CD38 expression, driven by the chronic low-grade inflammation associated with aging, which degrades NAD+ at an accelerating rate. The combination produces a progressive deficit that compounds with each decade of adult life.
The seven mammalian sirtuins — SIRT1 through SIRT7 — are NAD+-dependent enzymes that regulate an extraordinary breadth of cellular biology: chromatin structure and gene expression, metabolic sensing and adaptation, mitochondrial function and integrity, DNA repair coordination, and inflammatory gene regulation. Each reaction they catalyze consumes one molecule of NAD+. Their collective activity — and therefore the cellular maintenance processes they coordinate — is directly coupled to the NAD+ pool that aging progressively depletes. The full sirtuin biology is explored in depth in the article dedicated to their role in cellular maintenance.
Every cell in the human body sustains thousands of DNA lesions each day. The first-response enzymes of DNA repair — PARP1 and PARP2 — detect strand breaks and consume NAD+ to synthesize the molecular scaffolds that recruit the repair machinery. In aging tissue, where damage rates are elevated by accumulated oxidative burden and NAMPT-mediated recycling is declining, the balance between repair demand and NAD+ supply shifts — with consequences for the rate at which genomic damage can be addressed.
Three of the seven sirtuins — SIRT3, SIRT4, SIRT5 — reside in the mitochondrial matrix, with more than 100 documented mitochondrial protein substrates between them. The NAD+/NADH ratio that governs electron transport chain efficiency is itself determined by NAD+ availability in the mitochondrial compartment. And the PGC-1α axis that coordinates mitochondrial biogenesis in response to energy demand runs through SIRT1's NAD+-dependent deacetylation. Mitochondrial dysfunction — one of the most consistently documented hallmarks of cellular aging — is connected to NAD+ decline through multiple reinforcing mechanisms.
In the Salvage Pathway — the dominant route to NAD+ in adult human tissue — NAMPT converts nicotinamide to NMN in the rate-limiting step. NMN is then converted to NAD+ by NMNAT. NMN supplementation delivers this molecule downstream of the NAMPT bottleneck — at the point where the pathway's declining capacity most directly constrains NAD+ production. Whether provided endogenously by a well-functioning NAMPT or exogenously as a supplement, NMN occupies the same biochemical position: one enzymatic step from NAD+.
The NAD+ system is not isolated from daily biological patterns. Circadian biology regulates NAMPT expression across the 24-hour cycle — driven by the CLOCK/BMAL1 machinery — meaning NAD+ production capacity has a daily rhythm that disrupted sleep and irregular schedules flatten. Exercise activates AMPK and PGC-1α — converging on the same molecular nodes that NAD+/SIRT1 biology governs. Fasting shifts the NAD+/NADH ratio as cells transition to fat oxidation. These connections are mechanistic and documented.
II
Where NAD+ biology connects
to the hallmarks of aging.
The hallmarks of aging — the cellular and molecular features that characterize the aging process across species, formally described in a 2013 Cell paper and expanded in 2023 — provide the most rigorous framework for locating where NAD+ biology sits within aging science. Not every hallmark connects to NAD+. Where the connections exist, they run through specific, documented mechanisms. Acknowledging both the connections and their limits is part of treating the science with the seriousness it deserves.
Five of the twelve hallmarks have direct, mechanistically grounded connections to NAD+ and sirtuin biology: genomic instability through PARP-mediated DNA repair; deregulated nutrient sensing through sirtuins as one of the four major nutrient-sensing axes in the hallmarks framework; mitochondrial dysfunction through the three mitochondrial sirtuins and the NAD+/NADH ratio of the electron transport chain; chronic inflammation through the CD38-mediated NAD+ degradation that inflammatory signaling drives; and disabled macroautophagy through SIRT1's role in regulating autophagic flux. Three more hallmarks have documented peripheral connections. Four have no established direct connection to NAD+ biology — and naming that boundary is part of intellectual honesty about what this science does and does not address.
Twelve Hallmarks — NAD+ Connection Status
Where NAD+ and NMN biology
connect to aging — and where they do not.
Connection levels reflect documented mechanistic relationships — not product claims. All research cited here was conducted independently and did not involve any specific Codeage product.
Where the Science Is Developing
Three active areas in NMN
and aging biology.
The mechanistic foundation is established. The translation into confirmed human outcomes is an active, developing area — not a gap that undermines the science, but the frontier of a field moving quickly.
Research Area 01
Human pharmacokinetics — how NMN reaches tissues
How NMN distributes to specific tissues and is converted to NAD+ in different cellular compartments continues to be characterized in human studies. The dose-response relationship between NMN and tissue NAD+ levels in various organs, and the determinants of individual variation in NMN pharmacokinetics, are areas where the current literature provides partial rather than complete answers. New pharmacokinetic studies are regularly published, and the picture continues to develop.
Research Area 02
Human functional outcomes — what NAD+ biology means for measurable health
Human clinical studies examining specific functional parameters in the context of NMN and NAD+ precursor biology are accumulating — with published work examining muscle physiology, metabolic markers, and cardiovascular function in various populations. This body of evidence is growing. The science here is best described as developing, with the relationship between the established mechanistic biology and measurable human outcomes continuing to be characterized.
Research Area 03
Lifestyle interactions with the NAD+ system
The mechanistic connections between lifestyle and NAD+ — exercise converging on PGC-1α, sleep providing the nocturnal maintenance window, fasting shifting the sirtuin-active metabolic environment — are grounded in documented biology. How these interactions play out in the full human context continues to be an active area of investigation.
The Biology in Numbers
What the NAD+–aging relationship
looks like structurally.
5
Hallmarks of aging with direct mechanistic connections to NAD+, sirtuin, and PARP biology — in a framework of twelve
Genomic instability, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, and chronic inflammation all have direct, documented mechanistic connections to NAD+ biology. The concentration of connections in the cellular maintenance and energy metabolism hallmarks — rather than being distributed randomly across all twelve — reflects that the sirtuin–NAD+ axis touches the systems most central to how cells preserve their functional integrity across time. Studies were conducted independently and did not involve any specific Codeage product.
7
NAD+-dependent sirtuins — each governing distinct cellular maintenance processes through a shared cofactor dependency
The breadth of sirtuin biology — seven enzymes, each drawing on NAD+, each governing a distinct cellular domain — is what makes the NAD+ axis notable among longevity-relevant molecular systems. The sirtuin family collectively touches genomic stability, metabolic sensing, mitochondrial function, epigenetic regulation, and inflammatory control through a single shared cofactor dependency. It is that structural coherence — not any specific outcome claim — that positions NAD+ biology as worth understanding carefully.
1
Rate-limiting enzymatic step whose age-related decline is the primary mechanism of NAD+ production reduction in adult tissue
NAMPT catalyzes the single rate-limiting step of the Salvage Pathway: the conversion of nicotinamide to NMN. Its age-related decline in activity across multiple tissues is the primary mechanism by which NAD+ production falls as the body ages. NMN is the molecule that NAMPT produces — meaning it enters the pathway at precisely the point where NAMPT's declining activity creates the greatest constraint. This structural relationship is the specific reason NMN occupies the position it does in longevity biology research.
III
What precision looks like
in the science of biological aging.
The most important thing about the NAD+/NMN story in aging biology is not its scale — it is its specificity. This is not a molecule associated with something vague in the direction of health. It is a precursor to a specific molecule (NAD+) that serves as a specific cofactor for a specific family of enzymes (sirtuins and PARPs) whose roles in specific cellular maintenance processes are documented across decades of molecular biology research. The specificity is what makes the science worth taking seriously.
What intellectual honesty also requires is acknowledging where the mechanistic precision of the biology has not yet been matched by the completeness of human clinical evidence. The connections between NAD+ decline and the hallmarks of aging are real and documented at the mechanistic level. The question of how the cellular biology described here plays out in human beings across different populations, doses, and durations is a question the research community is actively working to characterize. The biology of NMN, NAD+, and cellular aging continues to be developed, and what is described here reflects the current state of a science that will look more complete as human data accumulates in the years ahead.
For the mechanistic depth behind each of the connections described here — the sirtuins article, the mitochondria article, the DNA repair article, and the NAMPT article each cover one mechanism in full depth. All connect to Cellular Longevity — Pillar 03 of The Longevity Code.
The specificity
is the credibility.
This is not a molecule associated
with something vague
in the direction of health.
Codeage · Pillar 03 · Cellular Longevity
Built for the
cellular long game.
Cellular Longevity is Pillar 03 of The Longevity Code — the dimension of the system built around NAD+ biology, mitochondrial health, and the science of cellular aging.
Explore Cellular Longevity →
